(Reuters) – (This March 14 story has been corrected to say third approval for treatment, not second approval, in paragraph 1, and to say the initial approval was in February …
"Bristol"
-
-
(Reuters) -The U.S. Food and Drug Administration’s staff on Wednesday raised concerns that it was unclear if Johnson & Johnson and Bristol Myers Squibb’s cancer cell therapies would benefit blood …
-
Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Robert Fuller, Special Agent in Charge of the New Haven Division of the Federal Bureau of Investigation, today …
-
(Reuters) – Bristol Myers Squibb CEO Christopher Boerner said on Monday the drugmaker expects to add 16 new products to its portfolio by the end of the decade. The drugmaker …
-
By Bhanvi Satija (Reuters) -Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business, marking the second multi-billion dollar deal …
-
By Michael Erman and Manas Mishra (Reuters) -Bristol Myers Squibb on Friday agreed to buy Karuna Therapeutics for $14 billion, gaining a promising new type of antipsychotic medicine to help …
-
BRISTOL TOWNSHIP, PA – On Wednesday, Daniel Stephen Dietrich, 46, of Palmyra, New Jersey, pleaded guilty to multiple charges, including voluntary manslaughter, related to a fatal incident in a McDonald’s …
-
BRISTOL, PA – The Bucks County District Attorney’s Office announced the arrest of Brian Nathaniel Harris, 28, of Pond Street, Bristol, on Tuesday. Harris faces over 160 charges, predominantly felonies, …
-
Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that TRAEVAUGHNN MORRISON, 27, of Hartford, was sentenced today by U.S. District Judge Alvin W. Thompson in Hartford …
-
(Reuters) – Bristol Myers Squibb has acquired Orum Therapeutics’ experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held …
-
By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday pushed back by a year the time frame for its new-product portfolio to hit $10 billion in revenue …
-
By Michael Erman (Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes …
-
(Reuters) – Bristol Myers Squibb said on Thursday it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies, over the …
-
By Brendan Pierson (Reuters) – Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood …
-
BRISTOL TOWNSHIP, PA – David Joseph Jenner, 40, was convicted on Tuesday, for the murder and assault of his cousin, Charlie R. Thomas Jr. The incident took place in December …
-
By Michael Erman (Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected and cut its full-year forecasts as two of its top drugs, the blood …
-
BRISTOL, CT – A sequence of events early on Wednesday morning has led to a suspect being taken into custody after a shooting incident. The victim, who was located near …
-
EVESHAM, NJ – Jason Mackenzie, a 43-year-old resident of Bristol, PA, was arrested onTuesday, in connection with multiple storage locker burglaries. The initial report was filed on January 14, when …
-
BRISTOL, PA – A Bristol Borough resident, Tyler Sullivan, 30, has been charged with the death of his 4-month-old son. The charges were issued on Thursday, by Magisterial District Judge …
-
By Michael Erman (Reuters) -Bristol Myers Squibb said on Wednesday evening its CEO Giovanni Caforio would step down in November and will be replaced by current Chief Commercialization Officer Chris …
-
(Reuters) -Bristol Myers Squibb Co said on Wednesday CEO Giovanni Caforio will step down in November and be succeeded by Chief Commercialization Officer Christopher Boerner. Boerner, who has been CCO …
-
By Michael Erman, Patrick Wingrove and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – The blood thinner Eliquis from Bristol Myers Squibb, Pfizer’s breast cancer drug Ibrance and AbbVie’s leukemia treatment Imbruvica …
-
By Jonathan Stempel NEW YORK (Reuters) -A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co of defrauding investors who stood to receive $6.4 billion had it …
-
By Michael Erman (Reuters) -Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts’ estimates due to a smaller-than-expected drop in sales of cancer drug Revlimid, which is …
-
Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that ALEXANDER PATTERSON, 34, of Bristol, was sentenced today by U.S. District Judge Omar A. Williams in Hartford …